Figure 6.
H19 Regulated Bcl-2 mRNA and Protein Expression through miR-877-3p
(A–C) The relative levels of miR-877-3p (A, n = 3), Bcl-2 mRNA (B, n = 3), and protein (C, n = 4) of cardiomyocytes co-treated with H19 siRNA and AMO-miR-877-3p. **p < 0.01, ***p < 0.001 versus control group; #p < 0.05, ##p < 0.01 versus siRNA of H19 group (H19 siRNA). (D–F) The relative level of miR-877-3p (D, n = 3), Bcl-2 mRNA (E, n = 3), and Bcl-2 protein (F, n = 6) of cardiac myocytes co-treated with H19 overexpression plasmid and miR-877-3p. *p < 0.05, ***p < 0.001 versus control group; #p < 0.05, ##p < 0.01, ###p < 0.001 versus H19 group (H19).